Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) is 25.64% higher on its value in year-to-date trading and has touched a low of $13.00 and a high of $24.27 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CPRX stock was last observed hovering at around $21.15 in the last trading session, with the day’s loss setting it -0.03%.
Currently trading at $21.12, the stock is -4.00% and 0.08% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.81 million and changing -0.14% at the moment leaves the stock 20.22% off its SMA200. CPRX registered 53.71% gain for a year compared to 6-month gain of 32.66%. The firm has a 50-day simple moving average (SMA 50) of $21.0866 and a 200-day simple moving average (SMA200) of $17.52875.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -1.03% loss in the last 1 month and extending the period to 3 months gives it a 3.94%, and is -2.63% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.29% over the week and 3.25% over the month.
Catalyst Pharmaceuticals Inc (CPRX) has around 167 employees, a market worth around $2.52B and $460.48M in sales. Current P/E ratio is 18.02 and Fwd P/E is 13.30. Profit margin for the company is 31.01%. Distance from 52-week low is 62.46% and -12.98% from its 52-week high. The company has generated returns on investments over the last 12 months (21.51%).
The EPS is expected to grow by 93.39% this year
429.0 institutions hold shares in Catalyst Pharmaceuticals Inc (CPRX), with institutional investors hold 86.92% of the company’s shares. The shares outstanding are 107.12M, and float is at 105.83M with Short Float at 5.68%. Institutions hold 81.72% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 18.69 million shares valued at $289.58 million. The investor’s holdings represent 16.0051 of the CPRX Shares outstanding. As of 2024-06-30, the second largest holder is DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) with 9.13 million shares valued at $141.38 million to account for 7.8141 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 8.1 million shares representing 6.9349 and valued at over $125.47 million, while STATE STREET CORP holds 5.1652 of the shares totaling 6.03 million with a market value of $93.46 million.
Catalyst Pharmaceuticals Inc (CPRX) Insider Activity
The most recent transaction is an insider sale by MCENANY PATRICK J, the company’s Chairman of Board of Directors. SEC filings show that MCENANY PATRICK J sold 98,345 shares of the company’s common stock on Nov 19 ’24 at a price of $21.19 per share for a total of $2.08 million. Following the sale, the insider now owns 4.48 million shares.
Catalyst Pharmaceuticals Inc disclosed in a document filed with the SEC on Nov 20 ’24 that MCENANY PATRICK J (Chairman of Board of Directors) sold a total of 72,500 shares of the company’s common stock. The trade occurred on Nov 20 ’24 and was made at $21.29 per share for $1.54 million. Following the transaction, the insider now directly holds 4.48 million shares of the CPRX stock.
Still, SEC filings show that on Nov 20 ’24, INGENITO GARY (Officer) Proposed Sale 38,000 shares at an average price of $21.20 for $0.81 million. The insider now directly holds shares of Catalyst Pharmaceuticals Inc (CPRX).
